Effects of Fibrates on Serum Metabolic Parameters
Author:
- 1 January 2002
- journal article
- review article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 18 (5) , 269-276
Abstract
SummaryFibric acid derivatives are a class of hypolipidaemic drugs used in the treatment of patients with hypertriglyceridaemia, mixed hyperlipidaemia and diabetic dyslipidaemia. Fibrate therapy re...Keywords
This publication has 75 references indexed in Scilit:
- Statin + fibrate combination therapyInternational Journal of Cardiology, 1999
- EditorialThe American Journal of Cardiology, 1998
- Micronised FenofibrateDrugs, 1997
- Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.Journal of Clinical Investigation, 1995
- Insulin action and glucose metabolism are improved by gemfibrozil treatment in hypertriglyceridemic patientsAtherosclerosis, 1995
- Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Effects of Combined Bezafibrate‐Simvastatin Appraised in Healthy SubjectsThe Journal of Clinical Pharmacology, 1992
- Double-blind comparison of bezafibrate versus placebo in male volunteers with hyperlipoproteinemiaAtherosclerosis, 1992
- Altering Triglyceride Concentrations Changes Insulin-Glucose Relationships in Hypertriglyceridemic Patients: Double-Blind Study With Gemfibrozil With Implications for AtherosclerosisDiabetes Care, 1991
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987